Work

The silencing of HER2/neu gene expression in a breast cancer cell model using cationic lipid based delivery systems.

Year: 2016
Type: dissertation
Abstract: RNA interference technology, based on the use of siRNA, has emerged as a promising approach in the treatment strategy to suppress disease-causing genes such as those associated with breast cancer (BC).Despite its potential as a form of therapy, instability and poor cellular uptake of the therapeutic nucleic acid have posed daunting challenges.The major hurdle for siRNA-based therapy is the evolution of nontoxic, stable and efficient delivery systems to channel siRNA into target cells.Accordingly, this study assesses the efficacy of two cationic lipid-based delivery systems to deliver intact siRNA which would target the Human Epidermal Growth Factor Receptor 2 (HER2/neu) oncogene in a BC cell model.A series of cationic liposomes were formulated using an equimolar ratio of the respective cytofectins together with the neutral lipid dioleoylphosphatidylethanolamine (DOPE).Sterically stabilized or stealth liposomes contained a 0-5 mol.% 1,2-Distearoyl-sn-glycero-3phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG 2000 ) grafting.Cryogenic-transmission electron microscopy (cryo-TEM) and dynamic light scattering measurements revealed that PEGylation generated smaller, defined structures when compared to their non-PEGylated counterparts.The hydrodynamic size ranges of the liposomal formulations and lipoplexes were 65-127 nm and 103-237 nm respectively, with moderate particle size distributions (polydispersity indices were <0.4).Liposomes bound and efficiently compacted pCMV-luc plasmid DNA (pDNA) and siRNA as evidenced in band shift and ethidium bromide intercalation assays respectively, while nuclease digestion assays demonstrated that the degradative effect of serum on lipoplex-associated nucleic acid was minimal.Cytotoxicity studies, involving the reduction of 3-(4, 5-dimethyl-2-thiazolyl)-2, 5diphenyl-2H-tetrazolium bromide (MTT), indicated that the pDNA and siRNA lipoplexes elicited a dose-dependent cytotoxic effect, with cell viability remaining above 70% and 50% respectively.Effective in vitro pCMV-luc pDNA and HER2/neu-specific siRNA transfections were achieved in all BC cell lines tested in the presence of serum.Gene expression studies indicated that the Chol-T:DOPE (0% PEG)/siRNA complexes induced the highest HER2/neu silencing effect at all tested N/P charge ratios, as observed from the significant fold-decrease in gene expression (> 10 000-fold, P<0.001).Western blot analysis further confirmed this trend and revealed a dose-dependent decrease in HER2/neu protein expression levels as indicated by a iii 160.28, 163.89 and 212.80-fold decrease in protein expression relative to the untreated SKBR-3 cells.Furthermore, the most active non-PEGylated Chol-T formulations were less cytotoxic and exceeded the knockdown level of Lipofectamine ® 3000 control (4.1-fold decrease).Results suggest that these cytofectin-based cationic liposomes with moderate degree of PEGylation have potential as vectors for trans-gene expression and HER2/neu siRNA gene silencing in BC cells.
Language: English
Open Access status: green
OpenAlex ID: W2919681674
Cites: 539
Cited by:
Related to: 10